Clincosm LogoSign in Get a demo

chronic hepatitis c

Showing 1 - 25 of 351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or

Active, not recruiting
  • Chronic Hepatitis C
  • People Who Inject Drugs
  • velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
  • Atlanta, Georgia
    Wellstar Atlanta Medical Center
May 31, 2023

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    Long Term Follow-up of Hepatitis C Cured Patients

    Completed
    • Chronic Hepatitis C
    • +2 more
      • (no location specified)
      Sep 19, 2022

      Long Term Follow up of Chronic HCV Patients Receiving DAAS

      Recruiting
      • Chronic Hepatitis c
        • Sohag, Egypt
          Sohag University Hospital
        Jun 29, 2022

        Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)

        Terminated
        Has Results
        • Chronic Hepatitis C
        • 20mg ezetimibe
        • +2 more
        • Hines, Illinois
          Edward Hines Jr. VA Hospital, Hines, IL
        May 10, 2022

        Determine Hepatitis C Virus Infection Prevalence Among Patients

        Completed
        • Chronic Hepatitis c
        • Vasculitis
          • Mexico City, Mexico
            Hospital General de Mexico
          Mar 15, 2022

          Hepatocellular Carcinoma in HIV-infected Patients

          Completed
          • Hepatocellular Carcinoma
          • +4 more
            • Orihuela, Alicante, Spain
            • +29 more
            Mar 15, 2022

            End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

            Withdrawn
            • End Stage Renal Disease
            • Chronic Hepatitis c
            • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
            • Boston, Massachusetts
              Massachusetts General Hospital
            Mar 4, 2022

            Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)

            Recruiting
            • Chronic Hepatitis c
            • lipid profile
            • +2 more
            • Assiut, Egypt
              Assiut University hospital
            Feb 23, 2022

            Chronic Hepatitis C Trial in Chapel Hill (VC-CBCS)

            Completed
            Has Results
            • Chronic Hepatitis C
            • VC-CBCS
            • Chapel Hill, North Carolina
              University of North Carolina at Chapel Hill
            Jan 6, 2022

            Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

            Completed
            Has Results
            • Chronic Hepatitis C
            • SOF/LDV (sofosbuvir/ledipasvir)
            • +3 more
            • Little Rock, Arkansas
            • +37 more
            Dec 1, 2021

            Fixed-dose Combination Sofosdac® 400mg/60mg in Chronic Hepatitis

            Completed
            • Chronic Hepatitis c
            • Sofosdac®
            • Boufarik, Blida, Algeria
            • +3 more
            Nov 16, 2021

            Chronic Kidney Disease, Chronic Hepatitis C Trial in Boston (Viekira Pak ± ribavirin, Mavyret)

            Completed
            Has Results
            • Chronic Kidney Disease
            • Chronic Hepatitis C
            • Boston, Massachusetts
              Massachusetts General Hospital
            Oct 5, 2021

            Enhancing Access to Care for Chronic Hepatitis C Infected

            Recruiting
            • Chronic Hepatitis c
            • Intravenous Drug Usage
              • Hong Kong, Please Select One ..., Hong Kong
                Man Fung Yuen
              Sep 28, 2021

              Chinese Participants With Chronic Hepatitis C (CHC)

              Terminated
              • Chronic Hepatitis C
                • Beijing, Beijing, China
                • +1 more
                Aug 27, 2021

                Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)

                Active, not recruiting
                • Chronic Hepatitis C
                • Porto Alegre, Rio Grande Do Sul, Brazil
                  Hospital de Clínicas de Porto Alegre
                Aug 24, 2021

                Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic Trial in Melbourne (EC clinic support - whole of practice interventions

                Recruiting
                • Hepatitis C
                • +2 more
                • EC clinic support - whole of practice interventions delivery through nurse-led model
                • Melbourne, Victoria, Australia
                  Burnet Institute
                Aug 22, 2021

                Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

                Recruiting
                • Chronic Hepatitis C
                • Chronic Hepatitis B
                • Tenofovir Alafenamide 25 MG
                • Sofosbuvir / Velpatasvir
                • Beijing, Beijing, China
                  Peking University First Hospital
                Aug 2, 2021

                Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

                Completed
                Has Results
                • Chronic Hepatitis C
                • Hepatitis C Virus
                • (no location specified)
                Jul 9, 2021

                Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

                Completed
                Has Results
                • Chronic Hepatitis C
                • +2 more
                • (no location specified)
                Jul 9, 2021

                Chronic Hepatitis C Trial in Parma (blood drawing)

                Completed
                • Chronic Hepatitis C
                • blood drawing
                • Parma, Italy
                  Unit of Infectious Diseases and Hepatology
                Jul 20, 2021

                Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

                Completed
                Has Results
                • Chronic Hepatitis C
                • +2 more
                • (no location specified)
                Jul 9, 2021

                Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

                Completed
                Has Results
                • Hepatitis C Virus Infection
                • +3 more
                • ABT-493 coformulated with ABT-530
                • (no location specified)
                Jul 9, 2021

                Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

                Completed
                Has Results
                • Chronic Hepatitis C
                • +2 more
                • (no location specified)
                Jul 9, 2021

                Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

                Completed
                Has Results
                • Chronic Hepatitis C
                • +2 more
                • (no location specified)
                Jul 9, 2021